Kuta (Antara Bali) - Indonesian vaccine producer PT Bio Farma will strengthen research facilities and technological processes jointly with universities while developing vaccines.
"If we work on it alone, research on biological products will take up to 15 years. Therefore, technological and research synergy must be conducted to shorten the wait," corporate secretary of PT Bio Farma, Rahman Rustan said here on Wednesday.
The company is currently focusing on vaccine production because demand is high.
Collaboration with universities, other companies, suppliers and marketing agents is needed to strengthen research and technological processes, according to him.
"In developed countries, companies normally conduct research jointly with universities," he added.
He stated that challenges facing the company in producing vaccines include expensive infrastructure, human resources, equipment and raw materials. (DWA/M038)
Related News
Bio Farma expands exports of vaccines to African Markets
Monday, 15 Oktober 2018 20:02
House Sets Up Working Committee On Fake Vaccine Control
Thursday, 21 Juli 2016 21:57
Indonesia Strives To Stamp Out Typhoid
Sunday, 3 Mei 2015 6:52
Bio Farma Working To Prevent Typhoid Disease
Saturday, 2 Mei 2015 18:01
Bio Farma Develops Vaccine For Typhus
Saturday, 2 Mei 2015 12:24
Govt Produces H5NI Clade 2.3.2 Vaccine
Monday, 14 Januari 2013 19:56
Unair Develops Bird Flu Vaccine
Thursday, 10 Januari 2013 15:30
Rabies Claims More Lives In West Sumatra
Monday, 10 Desember 2012 20:19
DCVMN Conference Commits To Technology Transfer
Friday, 2 November 2012 17:51
Mahendra Suhardono Named New DCVMN President
Friday, 2 November 2012 13:57
Bio Farma Prioritizes Domestic Demand
Wednesday, 31 Oktober 2012 17:58
Bio Farma Exports Products To 117 Countries
Wednesday, 31 Oktober 2012 10:33